Dor Biopharma Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (26)

Latest Posts

About This Stock More About This Stock
E Soligenix: Biotech Company Chosen By Italian Hedge Fund BxWorld
Article By: Graziano Martini
Wednesday, July 19, 2017 11:36 PM EST
BxWorld Fund entered a position in Soligenix (ticker SNGX), a biotech company with some interesting products for the cure of cancer and a range of products against bioterrorism and radioactive warfare.
In this article: SNGX
Read
Week In Review: China's Luxin Invests In $215 Million Funding For Intarcia's Long-Term Diabetes Device
Article By: ChinaBio® Today
Saturday, September 17, 2016 2:30 PM EST
Luxin Venture Capital of Shandong Province participated in the first closing of the latest funding round for Boston's Intarcia Therapeutics.
In this article: GSK, CUR, SCLN, SNGX, BGNE
Read
Soligenix And Rare Diseases
Article By: Anthony Alfidi
Wednesday, February 3, 2016 7:26 AM EST
Several US government research agreements support Soligenix's development of biodefense products. Using federal research funds is a good move if it keeps the rest of an enterprise moving toward its larger business goals.
In this article: SNGX
Read
Week In Review: Fosun Plans Hong Kong IPO Of IVD Subsidiary
Article By: ChinaBio® Today
Saturday, December 26, 2015 2:28 PM EST
Fosun Pharma is planning to spin off and conduct a Hong Kong IPO of a subsidiary, medical device maker Yaneng Bioscience of Shenzhen.
In this article: SCLN, SNGX
Read

PARTNER HEADLINES

Latest Tweets for $SNGX

No tweets yet!